Sangamo Therapeutics
SGMO
#9117
Rank
HK$0.93 B
Marketcap
HK$2.51
Share price
-6.74%
Change (1 day)
-62.41%
Change (1 year)

EPS for Sangamo Therapeutics (SGMO)

EPS in 2025 (TTM): -HK$3.43

According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$3.45. In 2024 the company made an earnings per share (EPS) of -HK$3.99.

EPS history for Sangamo Therapeutics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$3.43-14.21%
2024-HK$3.99
2022-HK$9.790.81%
2021-HK$9.7133.33%
2020-HK$7.286.9%
2019-HK$6.8122.54%
2018-HK$5.561.43%
2017-HK$5.48-31.37%
2016-HK$7.9975.86%
2015-HK$4.5448.72%
2014-HK$3.05-17.02%
2013-HK$3.689.3%
2012-HK$3.37-39.44%
2011-HK$5.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.25-2,631.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$112.24-3,356.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$69.16-2,106.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-HK$28.90 738.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$53.65-1,656.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$57.26-1,761.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$14.10-509.09%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$14.26-513.64%๐Ÿ‡บ๐Ÿ‡ธ USA